Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL ANTIBODIES SPECIFIC FOR CTHRC1 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/250204
Kind Code:
A1
Abstract:
The present invention relates to antibodies binding to CTHRC1 and uses thereof.

Inventors:
KOH SANG SEOK (KR)
KANG MIN KYUNG (KR)
PARK SO YEON (SG)
Application Number:
PCT/IB2020/055561
Publication Date:
December 17, 2020
Filing Date:
June 15, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PRESTIGE BIOPHARMA PTE LTD (SG)
International Classes:
C07K16/18; A61K39/00; A61P35/00; G01N33/574
Foreign References:
KR20140144934A2014-12-22
KR20110082669A2011-07-20
US20100183512A12010-07-22
KR20070030084A2007-03-15
KR20130094640A2013-08-26
Other References:
"Mechanistic Studies and Antibody Therapeutic Application of CTHRC1, a novel factor expressed in cancer cells", KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, 7 January 2013 (2013-01-07), pages 1 - 60, XP009524873
PARK ET AL., CARCINOGENESIS, vol. 34, 2013, pages 694
LEE ET AL., EXPMOLMED, vol. 48, 2016, pages e261
KOEHERMILSTEIN, NATURE, vol. 256, 1976, pages 495
BARBAS, METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, vol. 2, 1991, pages 119
J. VIROL., vol. 75, no. 14, July 2001 (2001-07-01), pages 6692 - 9
WINTER ET AL., ANN. REV. IMMUNOL., vol. 12, 1994, pages 433
See also references of EP 3985021A4
Download PDF: